SAN JOSE, Calif.--(BUSINESS WIRE)--Vital Connect announced today that its FDA-cleared wearable biosensor, HealthPatch® MD, is now available for use in clinical trials in partnership with Medidata (NASDAQ: MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences. HealthPatch® MD can be used with Medidata’s industry-leading technology platform (Medidata Clinical Cloud®) and its mobile app for patient-reported outcomes (Medidata Patient Cloud®) to further re
| < Prev | Next > |
|---|
